HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist.

Abstract
The acute inflammatory response following traumatic brain injury (TBI) has been shown to play an important role in the development of secondary tissue damage. The proinflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNFalpha), are induced early after brain injury and have been implicated in the delayed damage. The IL-1 receptor antagonist (IL-1ra) has been shown to modulate the proinflammatory cytokine cascade by blocking the binding of IL-1 to its signaling receptor. In this study, we investigated the effect of transgenic overexpression of IL-1ra on the cytokine expression and neurological damage in a closed head injury (CHI) model of TBI. The neurological recovery, as analyzed by neurological severity score (NSS), was significantly higher in transgenic mice overexpressing the human secreted form of IL-1ra in astrocytes, directed by the murine glial fibrillary acidic protein promoter, as compared to wild-type mice. Analysis of tissue levels of cytokines by ELISA showed increased levels of TNFalpha in the cerebral cortex from the wild type mice 1 h after injury. After 4 h significant increases in the levels of IL-1beta and IL-6 were observed in the wild type mice. In the transgenic mice, on the other hand, no effect on TNFalpha levels was observed and no significant increases in IL-1beta and IL-6 levels could be detected until 6 h after injury. Thus, it can be concluded that blockage of IL-1 signaling by elevated levels of IL-1ra has a neuroprotective effect, in agreement with previous reports, and that central overexpression of IL-1ra results in delayed proinflammatory cytokine induction and improved neurological recovery after traumatic brain injury.
AuthorsRoya Tehranian, Siv Andell-Jonsson, Sara M Beni, Ido Yatsiv, Esther Shohami, Tamas Bartfai, Johan Lundkvist, Kerstin Iverfeldt
JournalJournal of neurotrauma (J Neurotrauma) Vol. 19 Issue 8 Pg. 939-51 (Aug 2002) ISSN: 0897-7151 [Print] United States
PMID12225654 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • IL1RN protein, human
  • Il1rn protein, mouse
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Interleukin-6
  • Sialoglycoproteins
  • Tumor Necrosis Factor-alpha
Topics
  • Animals
  • Brain (metabolism)
  • Brain Edema (etiology)
  • Brain Injuries (complications, metabolism)
  • Enzyme-Linked Immunosorbent Assay
  • Hippocampus (injuries, metabolism)
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 (biosynthesis)
  • Interleukin-6 (biosynthesis)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Transgenic
  • Recovery of Function
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sialoglycoproteins (biosynthesis)
  • Time Factors
  • Trauma Severity Indices
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: